Intera Oncology Inc. (now a part of Boston Scientific)

About

Intera Oncology Inc. is a medical technology company based in Newton Center, Massachusetts, specializing in Hepatic Artery Infusion (HAI) therapy for liver-dominant cancers. Founded in 2019 by Drs. Jonathan Reis and David Dove, the company aims to improve survival outcomes for patients with metastatic colorectal cancer and intrahepatic cholangiocarcinoma through targeted chemotherapy delivery. The flagship product, the Intera 3000 HAI Pump, is an implantable device that delivers chemotherapy directly to the liver via the hepatic artery. This approach enhances drug concentration in tumors while reducing systemic side effects. Intera Oncology also offers therapy solutions that include pump implantation, chemotherapy administration, and patient monitoring. In November 2024, the company was acquired by Boston Scientific to expand its interventional oncology portfolio, integrating its innovative HAI technology into a broader range of treatment options.